{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:06:44Z","timestamp":1788944804956,"version":"build-2803163510"},"reference-count":29,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Colorectal cancer is the third most commonly diagnosed cancer in the world. Liver metastases are frequent, adversely affecting patient prognosis. We compared progression-free survival and overall survival in colorectal cancer patients with liver metastasis treated with surgical resection or stereotactic body radiotherapy. No previous study had shown superiority of one treatment option over the other. Methods: We conducted a retrospective cohort study of 40 colorectal cancer patients with liver metastasis treated with surgical resection or stereotactic body radiotherapy at the Hebrew University-Hadassah Medical Center. Patient demographics, tumor characteristics, treatment details, and survival outcomes were analyzed. Kaplan\u2013Meier curves and log-rank tests were used for survival analysis. Results: The median overall survival for the entire cohort was 44 months (95% CI 29\u201359 months). In patients treated with surgical resection, the median overall survival was 51 months (95% CI: 36\u201367 months), while in patients treated with stereotactic body radiotherapy the median overall survival was 32 months (95% CI: 21\u201343 months), a non-statistically significant result (p = 0.306). The number of lobes involved did not significantly impact overall survival (p = 0.214). Additionally, it did not significantly affect progression-free survival (p = 0.41). Liver metastases located in the left lobe led to considerably worse progression-free survival compared to other regions involved, specifically in the patients who underwent surgery. Conclusions: Our findings underscore the importance of personalized treatment strategies tailored to the distinct characteristics of colorectal cancer patients with liver metastasis. Currently, surgical resection remains the standard of care. Further research is warranted to address the possibility of extending SBRT to first-line treatment in selected unresectable patients.<\/jats:p>","DOI":"10.3390\/cancers18182917","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:05:43Z","timestamp":1788941143000},"page":"2917","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SBRT for Colorectal Cancer Liver Metastasis Is a Safe and Effective Treatment Option\u2014A Single Institution Retrospective Analysis"],"prefix":"10.3390","volume":"18","author":[{"given":"Nitsan","family":"Peled Oved","sequence":"first","affiliation":[{"name":"Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel"},{"name":"Department of Military Medicine and \u201cTzamert\u201d, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Marc","family":"Wygoda","sequence":"additional","affiliation":[{"name":"Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"given":"Adi","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"given":"Mor","family":"Oved","sequence":"additional","affiliation":[{"name":"Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel"},{"name":"Department of Military Medicine and \u201cTzamert\u201d, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Philip","family":"Blumenfeld","sequence":"additional","affiliation":[{"name":"Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"given":"Ayala","family":"Hubert","sequence":"additional","affiliation":[{"name":"Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"given":"Aron","family":"Popovtzer","sequence":"additional","affiliation":[{"name":"Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"given":"Tamar","family":"Peretz","sequence":"additional","affiliation":[{"name":"Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5077-9249","authenticated-orcid":false,"given":"Aviad","family":"Zick","sequence":"additional","affiliation":[{"name":"Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7915-4250","authenticated-orcid":false,"given":"Tal Falick","family":"Michaeli","sequence":"additional","affiliation":[{"name":"Department of Medical and Radiation Oncology, Sharett Institute of Oncology, Hadassah Medical Center, Jerusalem 91120, Israel"},{"name":"Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem 91120, Israel"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"ref_1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Engstrand, J., Nilsson, H., Str\u00f6mberg, C., Jonas, E., and Freedman, J. (2018). Colorectal cancer liver metastases\u2014A population-based study on incidence, management and survival. BMC Cancer, 18.","DOI":"10.1186\/s12885-017-3925-x"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1002\/cncr.34931","article-title":"American Radium Society Appropriate Use Criteria for the use of liver-directed therapies for nonsurgical management of liver metastases: Systematic review and guidelines","volume":"129","author":"Hallemeier","year":"2023","journal-title":"Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/jso.23138","article-title":"Liver metastases from colorectal cancer: Technique of liver resection","volume":"107","author":"Heinrich","year":"2013","journal-title":"J. Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/02656736.2021.1923836","article-title":"Stereotactic body radiation therapy for colorectal liver metastases","volume":"39","author":"Mohamad","year":"2022","journal-title":"Int. J. Hyperth."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Renzulli, M., Brandi, N., Pecorelli, A., Pastore, L.V., Granito, A., Martinese, G., Tovoli, F., Simonetti, M., Dajti, E., and Colecchia, A. (2022). Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers. Diagnostics, 12.","DOI":"10.3390\/diagnostics12040834"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hackl, C., Neumann, P., Gerken, M., Loss, M., Klinkhammer-Schalke, M., and Schlitt, H.J. (2014). Treatment of colorectal liver metastases in Germany: A ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-810"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00534-011-0460-z","article-title":"A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: Multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery","volume":"19","author":"Beppu","year":"2012","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jamcollsurg.2009.12.040","article-title":"Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1600 Patients during Two Decades at a Single Institution","volume":"210","author":"House","year":"2010","journal-title":"J. Am. Coll. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1477-2574.2012.00440.x","article-title":"Evaluating agreement regarding the resectability of colorectal liver metastases: A national case-based survey of hepatic surgeons","volume":"14","author":"Mohammad","year":"2012","journal-title":"HPB"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jss.2010.07.022","article-title":"Impact of complications after surgery for colorectal liver metastasis on patient survival","volume":"164","author":"Schepers","year":"2010","journal-title":"J. Surg. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1007\/s00268-023-07043-z","article-title":"Risk Factors for Postoperative Complications Following Resection of Colorectal Liver Metastases and the Impact on Long-Term Survival: A Population-Based National Cohort Study","volume":"47","author":"Scherman","year":"2023","journal-title":"World J. Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4254\/wjh.v11.i2.150","article-title":"Colorectal liver metastases: An update on multidisciplinary approach","volume":"11","author":"Chow","year":"2019","journal-title":"World J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13014-018-0969-2","article-title":"Stereotactic Body Radiotherapy (SBRT) for liver metastasis\u2014Clinical outcomes from the international multi-institutional RSSearch\u00ae Patient Registry","volume":"13","author":"Mahadevan","year":"2018","journal-title":"Radiat. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_16","first-page":"183","article-title":"The evolving role of radiation therapy as treatment for liver metastases","volume":"2","author":"Alrabiah","year":"2022","journal-title":"J. Natl. Cancer Cent."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijrobp.2017.04.010","article-title":"Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases","volume":"99","author":"McPartlin","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.prro.2015.10.011","article-title":"Long-term safety and efficacy of stereotactic body radiation therapy for hepatic oligometastases","volume":"6","author":"Goodman","year":"2016","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13014-015-0369-9","article-title":"Stereotactic radiation therapy for liver metastases: Factors affecting local control and survival","volume":"10","author":"Andratschke","year":"2015","journal-title":"Radiat. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1634\/theoncologist.2012-0092","article-title":"Review and Uses of Stereotactic Body Radiation Therapy for Oligometastases","volume":"17","author":"Alongi","year":"2012","journal-title":"Oncologist"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/SLA.0000000000001427","article-title":"Resection Margin and Survival in 2368 Patients Undergoing Hepatic Resection for Metastatic Colorectal Cancer: Surgical Technique or Biologic Surrogate?","volume":"262","author":"Sadot","year":"2015","journal-title":"Ann. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Molla, M., Fernandez-Plana, J., Albiol, S., Fondevila, C., Vollmer, I., Cases, C., Garcia-Criado, A., Capdevila, J., Conill, C., and Fundora, Y. (2021). Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT. J. Clin. Med., 10.","DOI":"10.3390\/jcm10102131"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation Therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.radonc.2018.06.035","article-title":"Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review","volume":"129","author":"Petrelli","year":"2018","journal-title":"Radiother. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/jgh3.12325","article-title":"Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local therapies for elderly, vulnerable patients","volume":"4","author":"Gotohda","year":"2020","journal-title":"JGH Open"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Puijk, R.S., Ruarus, A.H., Vroomen, L.G.P.H., Van Tilborg, A.A.J.M., Scheffer, H.J., Nielsen, K., De Jong, M.C., De Vries, J.J.J., Zonderhuis, B.M., and Eker, H.H. (2018). Colorectal liver metastases: Surgery versus thermal ablation (COLLISION)\u2014A phase III single-blind prospective randomized controlled trial. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4716-8"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s11605-008-0494-y","article-title":"Operative mortality after hepatic resection: Are literature-based rates broadly applicable?","volume":"12","author":"Asiyanbola","year":"2008","journal-title":"J. Gastrointest. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2016.10.024","article-title":"Central liver toxicity after SBRT: An expanded analysis and predictive nomogram","volume":"122","author":"Toesca","year":"2017","journal-title":"Radiother. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kong, Y., Ma, Y., Zhao, X., Pan, J., Xu, Z., and Zhang, L. (2021). Optimizing the Treatment Schedule of Radiotherapy Combined with Anti-PD-1\/PD-L1 Immunotherapy in Metastatic Cancers. Front Oncol., 11.","DOI":"10.3389\/fonc.2021.638873"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/2917\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:15:55Z","timestamp":1788941755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/2917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":29,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18182917"],"URL":"https:\/\/doi.org\/10.3390\/cancers18182917","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}